StockNews.com Initiates Coverage on Trevena (NASDAQ:TRVN)
Equities researchers at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research report issued on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Several other research analysts have also issued reports on TRVN. JMP Securities reissued a “market outperform” rating and issued a $2.00 price target […]